HemaCare Co. (OTCMKTS:HEMA – Get Free Report)’s stock price was up 0.6% during trading on Tuesday . The company traded as high as $25.31 and last traded at $25.31. Approximately 5,400 shares traded hands during trading, a decline of 86% from the average daily volume of 39,950 shares. The stock had previously closed at $25.16.
HemaCare Price Performance
The firm has a 50-day moving average price of $25.31 and a 200 day moving average price of $25.31.
About HemaCare
HemaCare Corporation provides human-derived primary blood cells and tissues for biomedical research, and supporting cell therapy clinical trials and commercialization with apheresis collections in the United States. The company specializes in the customized collection, isolation, and testing of primary human blood cells and other biological products for research protocols and cellular therapy.
Featured Stories
- Five stocks we like better than HemaCare
- Roth IRA Calculator: Calculate Your Potential Returns
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for HemaCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HemaCare and related companies with MarketBeat.com's FREE daily email newsletter.
